tradingkey.logo
搜尋

Cardio Diagnostics Holdings Inc

CDIO
添加自選
1.550USD
-0.050-3.13%
收盤 07-24 16:00美東報價延遲15分鐘
4.59M總市值
0.06本益比TTM

Cardio Diagnostics Holdings Inc

1.550
-0.050-3.13%

關於 Cardio Diagnostics Holdings Inc 公司

Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.

Cardio Diagnostics Holdings Inc簡介

公司代碼CDIO
公司名稱Cardio Diagnostics Holdings Inc
上市日期Nov 23, 2021
CEODogan (Meeshanthini V)
員工數量13
證券類型Ordinary Share
年結日Nov 23
公司地址311 W. Superior Street
城市CHICAGO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編60645
電話18552269991
網址
公司代碼CDIO
上市日期Nov 23, 2021
CEODogan (Meeshanthini V)

Cardio Diagnostics Holdings Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
107.26K
+96.01%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Paul F. Burton, J.D.
Mr. Paul F. Burton, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy J. Betts
Ms. Wendy J. Betts
Independent Director
Independent Director
--
--
Mr. Peter K. Fung
Mr. Peter K. Fung
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
107.26K
+96.01%
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
--
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
--
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--

常見問題

Cardio Diagnostics Holdings Inc的前五大股東是誰?

Cardio Diagnostics Holdings Inc的前五大股東如下:Mr. Timur Dogan, Ph.D.

有多少機構持有Cardio Diagnostics Holdings Inc(CDIO)的股份?

截至2026Q1,共有38家機構持有Cardio Diagnostics Holdings Inc的股份,合計持有的股份價值約為138.49K,占公司總股份的4.68% 。與2025Q4相比,機構持股有所增加,增幅為-23968.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有